Microsporidia infection in patients with autoimmune diseases

Conclusion: There was a significant increase in microsporidia infection in autoimmune disease patients undergoing treatment with TNF-α antagonists, and the duration of treatment is one of the risk factors. The study highlights the importance of microsporidia testing in immunocompromised patients, particularly those undergoing treatment with anti-TNF-α drugs and emphasises the need for awareness among clinicians regarding this opportunistic parasite.

Source: Indian Journal of Medical Microbiology - November 4, 2020 Category: Microbiology Authors: Khadiga Ahmed Ismail Yousry A Hawash Taisir Saber Emad M Eed Amany S Khalifa Khalaf F Alsharif Saleh A Alghamdi Ahmed M Khalifa Osama Mahmoud Khalifa Hatem K Althubiti Gala M Alsofyani Source Type: research